Efficacy of 1,064 nm Q-Switched Nd:YAG Laser treatment for the Nevus of Ota
DOI:
https://doi.org/10.66344/jpad.v31i4.1716Abstract
Objective To evaluate the efficacy of 1064nm Q-switched Nd:YAG laser in the treatment of Nevus of Ota.
Methods This study was conducted in Department of Dermatology, Unit-II, KEMU/Mayo Hospital, Lahore. A total of 100 patients of nevus of Ota (both unilateral and bilateral) with Fitzpatrick skin type III to V were included in this study. Baseline photographs and Pigment area and Severity Index (PSI) score was recorded. All patients were treated with 1064nm Q-switched Nd:YAG laser at fluence of 500-600 V and frequency of 5Hz. A total of 10 sessions at 2 weeks interval were given. Final assessment was done at 4 weeks after last session. Improvement was measured in terms of percentage reduction in baseline PSI score.
Results Mean age of the patients was 24.35±5.70 years. There were 15.0% males and 85.0% females. Majority of the patients had duration of lesion > 15 years. Most of the patients presented with skin type IV. 52.0% patients showed more than 50% clinical improvement. Improvement was higher in females (56%) and in patients with skin type III (50%) and IV (60%). Stratification with regards to age and duration of lesion showed no statistically significant difference.
Conclusion Fifty two % of patients of nevus of Ota treated with 1064 nm Q-switched Nd:YAG laser showed more than 50% improvement.
References
1. Aurangabadkar S. QYAG5 Q-switched Nd:YAG Laser Treatment of Nevus of Ota: An Indian Study of 50 Patients. J Cutan Aesthet Surg.2008;1:80-4.
2. Nam JH, Kim HS, Choi YJ, Jung HJ, Kim WS. Treatment and Classification of Nevus of Ota: A Seven-Year Review of a Single Institution's Experience. Ann Dermatol. 2017;29(4):446-453.
doi: 10.5021/ad.2017.29.4.446.
3. Braff MH, Bardan A, Nizet V, Gallo RL. Cutaneous defense mechanisms by antimicrobial peptides. J Invest Dermatol. 2005;125:9-13.
4. Wang BQ, Shen ZY, Fei Y, Li H, Liu JH, Xu H, et al. A population-based study of acquired bilateral nevus-of-Ota-like macules in Shanghai, China. J Invest Dermatol. 2011;131:358-62.
5. Kar HK, Gupta L. 1064 nm Q switched Nd: YAG laser treatment of nevus of Ota: An Indian open label prospective study of 50 patients. Indian J Dermatol Venereol Leprol 2011;77:565-70.
6. Rani S, Sardana K. Variables that predict response of nevus of ota to lasers. J Cosmet Dermatol.2019;18(2):464-8.
doi: 10.1111/jocd.12875. Epub 2019 Feb 5. PMID: 30723997
7. Solanki J, Gupta S, Sharma N, Singh M, Bhateja S5. Nevus of Ota"- a rare pigmentation disorder with intraoral findings. J Clin Diagn Res.2014;8: ZD49-50.
8. Mahmoudi H, Daneshpazhooh M, Nourmohammadpour P, Lakzadeh L, Daneshmand R, Etesami I. Successful treatment of a patient with multicolored nevus of Ota using a combination of 1064 and 532 nm Q-switched Nd:YAG lasers. J Cosmet Laser Ther.2020;22(1):27-9.
9. Moody MN, Landau JM, Vergilis-Kalner IJ, Goldberg LH, Marquez D, Friedman PM. 1,064-nm Q-switched neodymium-doped yttrium aluminum garnet laser and 1,550-nm fractionated erbium-doped fiber laser for the treatment of nevus of Ota in Fitzpatrick skin type IV. Dermatol Surg.2011;37(8):1163-7.
doi: 10.1111/j.1524-4725.2011.02000.x.
10. Kar HK, Gupta L. 1064 nm Q switched Nd: YAG laser treatment of nevus of Ota: An Indian open label prospective study of 50 patients. Indian J Dermatol Venereol Leprol.2011;77:565-70.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Wajeeha Nusrat
This work is licensed under a Creative Commons Attribution 4.0 International License.
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.
